Shriphal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 4.59 M
as on 06-12-2024
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2017)
- Ebitda
- Net Worth -0.05%
(FY 2017)
- Total Assets -0.05%
(FY 2017)
About Shriphal Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 4.59 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Gupta, Dinesh Agarwal, Mahesh Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U02423MP1986PLC003573
- Company No.
003573
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Sep 1986
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Gwalior, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shriphal Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Gupta  | Director | 14-May-2010 | Current |
| Dinesh Agarwal | Director | 30-Sep-2004 | Current |
| Mahesh Singh | Director | 14-May-2010 | Current |
| Rekha Sharma | Director | 02-Mar-2019 | Current |
Financial Performance of Shriphal Pharmaceuticals.
Shriphal Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shriphal Pharmaceuticals?
In 2017, Shriphal Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shriphal Pharmaceuticals?
Unlock and access historical data on people associated with Shriphal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shriphal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shriphal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
